Development and Evaluation of the Quality of Life Scale for Children With Visual Impairments in China.

children physical wellbeing quality of life reliability validity visual impairments

Journal

Frontiers in pediatrics
ISSN: 2296-2360
Titre abrégé: Front Pediatr
Pays: Switzerland
ID NLM: 101615492

Informations de publication

Date de publication:
2022
Historique:
received: 10 07 2021
accepted: 23 02 2022
entrez: 7 4 2022
pubmed: 8 4 2022
medline: 8 4 2022
Statut: epublish

Résumé

Visual impairments related to non-correctable vision loss, including blindness and low vision, have been consistently shown to lower a person's health-related quality of life. This study assessed the reliability, validity, and discrimination of the Quality of Life Scale for Children with Visual Impairments (QOLS-CVI) in China. The Pediatric Quality of Life Inventory™ 4.0 and World Health Organization Quality of Life-Disability Scale for physical disability were selected to define conceptual frameworks and item libraries based on relevant existing studies. According to two rounds of expert consultations and group discussions, some items were modified, and the draft scale was developed. Two item selection processes based on classical test theory and item response theory were used to conduct a preliminary survey and a formal survey in special schools in Shanxi and Hebei Provinces. Finally, the reliability and validity of the quality of life scale for visually impaired children in China were verified. The final QOLS-CVI consisted of 38 items, 10 subdomains, and 6 domains. Reliability was verified by Cronbach's alpha coefficient, split-half reliability, and test-retest reliability (Cronbach's alpha for the full scale, 0.841; split-half reliability, 0.629; and test-retest reliability, 0.888). The validity results showed that the multidimensional scale met expectations: exploratory factor analysis and confirmatory factor analysis indicated good fitting models for children with visual impairments. The QOLS-CVI was determined to be reliable and valid and to have strong feasibility and effectiveness. This scale can be used as an evaluation tool to study the QOL and social-participation ability of children with visual impairments.

Sections du résumé

Background UNASSIGNED
Visual impairments related to non-correctable vision loss, including blindness and low vision, have been consistently shown to lower a person's health-related quality of life. This study assessed the reliability, validity, and discrimination of the Quality of Life Scale for Children with Visual Impairments (QOLS-CVI) in China.
Methods UNASSIGNED
The Pediatric Quality of Life Inventory™ 4.0 and World Health Organization Quality of Life-Disability Scale for physical disability were selected to define conceptual frameworks and item libraries based on relevant existing studies. According to two rounds of expert consultations and group discussions, some items were modified, and the draft scale was developed. Two item selection processes based on classical test theory and item response theory were used to conduct a preliminary survey and a formal survey in special schools in Shanxi and Hebei Provinces. Finally, the reliability and validity of the quality of life scale for visually impaired children in China were verified.
Results UNASSIGNED
The final QOLS-CVI consisted of 38 items, 10 subdomains, and 6 domains. Reliability was verified by Cronbach's alpha coefficient, split-half reliability, and test-retest reliability (Cronbach's alpha for the full scale, 0.841; split-half reliability, 0.629; and test-retest reliability, 0.888). The validity results showed that the multidimensional scale met expectations: exploratory factor analysis and confirmatory factor analysis indicated good fitting models for children with visual impairments.
Conclusions UNASSIGNED
The QOLS-CVI was determined to be reliable and valid and to have strong feasibility and effectiveness. This scale can be used as an evaluation tool to study the QOL and social-participation ability of children with visual impairments.

Identifiants

pubmed: 35386258
doi: 10.3389/fped.2022.739296
pmc: PMC8979288
doi:

Types de publication

Journal Article

Langues

eng

Pagination

739296

Informations de copyright

Copyright © 2022 Liu, Evans, Wang, Hu, Tong, Li, Tian, Li, Zhang, He and Zheng.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

J Cataract Refract Surg. 2010 Jul;36(7):1181-8
pubmed: 20610098
J Clin Epidemiol. 2001 May;54(5):475-81
pubmed: 11337210
Lancet. 2006 Jul 29;368(9533):365
pubmed: 16876661
Br J Ophthalmol. 2013 Nov;97(11):1369-81
pubmed: 23743433
Int J Cancer Suppl. 1999;12:39-45
pubmed: 10679869
Qual Life Res. 2005 Aug;14(6):1633-9
pubmed: 16110942
J Pers Assess. 2005 Jun;84(3):228-38
pubmed: 15907159
J Cataract Refract Surg. 2009 Mar;35(3):504-13
pubmed: 19251145
Psychiatry Res. 2018 May;263:173-180
pubmed: 29573656
Arch Dis Child. 1998 Apr;78(4):381-6
pubmed: 9623409
BMC Public Health. 2015 Jul 11;15:637
pubmed: 26163383
Child Maltreat. 2016 Feb;21(1):37-46
pubmed: 26655211
Br J Ophthalmol. 2012 May;96(5):614-8
pubmed: 22133988
J Sports Sci. 2019 Jun;37(11):1205-1211
pubmed: 30499758
J Clin Epidemiol. 2009 Sep;62(9):991-7
pubmed: 19216054
Qual Life Res. 2010 May;19(4):571-84
pubmed: 20217246
Int J Cancer Suppl. 1999;12:52-7
pubmed: 10679871
Optom Vis Sci. 2007 Aug;84(8):656-8
pubmed: 17700329
Invest Ophthalmol Vis Sci. 2003 Sep;44(9):4131-9
pubmed: 12939337
PLoS One. 2014 Nov 21;9(11):e113166
pubmed: 25415751
Am J Ophthalmol. 1999 Jul;128(1):54-62
pubmed: 10482094
Patient. 2014;7(1):23-35
pubmed: 24403095
PLoS One. 2013;8(2):e55912
pubmed: 23418474
Am J Ophthalmol. 2004 Sep;138(3):362-72
pubmed: 15364217
Psychol Belg. 2018 Jan 04;57(4):190-209
pubmed: 30479801
Optom Vis Sci. 2012 Nov;89(11):1601-10
pubmed: 23069725
Health Qual Life Outcomes. 2014 Dec 09;12:176
pubmed: 25492701
Invest Ophthalmol Vis Sci. 2011 Mar 01;52(3):1632-40
pubmed: 21178144
J Clin Oncol. 1993 Mar;11(3):570-9
pubmed: 8445433
Health Qual Life Outcomes. 2013 Oct 22;11:174
pubmed: 24148800

Auteurs

Jie Liu (J)

School of Public Health, Shanxi Medical University, Taiyuan, China.

Richard Evans (R)

College of Engineering, Design and Physical Sciences, Brunel University London, London, United Kingdom.

Yanjun Wang (Y)

Service Center of Shanxi Medical and Health Institutions, Taiyuan, China.

Beibei Hu (B)

School of Public Health, Shanxi Medical University, Taiyuan, China.

Yan Tong (Y)

School of Public Health, Shanxi Medical University, Taiyuan, China.

Shaoqiong Li (S)

Center for Information, Chinese Center for Disease Control and Prevention, Beijing, China.

Zhiqiang Tian (Z)

School of Public Health, Shanxi Medical University, Taiyuan, China.

Jing Li (J)

School of Public Health, Shanxi Medical University, Taiyuan, China.

Cuihua Zhang (C)

Physiatry Department, Hospital of Traditional Chinese Medicine, Taiyuan, China.

Lu He (L)

School of Public Health, Shanxi Medical University, Taiyuan, China.

Jianzhong Zheng (J)

School of Public Health, Shanxi Medical University, Taiyuan, China.

Classifications MeSH